From: Treating primary immunodeficiencies with defects in NK cells: from stem cell therapy to gene editing
Disease | OMIM number | Mutated gene | Locus | Mutation |
---|---|---|---|---|
CNKD1 | 614172 | GATA2 | 3q21.3 | c.1061C>T |
IMD54 | 609981 | MCM4 | 8q11.21 | 71-2A-G |
DKCB | 608833 | RTEL1 | 20q13.33 | c.3791G>A |
IMD55 | 610608 | GINS1 | 20p11.21 | c.247C-T |
IMD32A-32B | 601565 | IRF8 | 16q24.1 | T80A |
IMD20 | 615707 | FCGR3A | 1q23.3 | c.230 T-A |
FHL2 | 267700 | PRF1 | 9q21.3-q22 | c.1122G>A |
FHL4 | 603552 | STX11 | 6q24.2 | c.173T>C |
GS2 | 607624 | RAB27A | 15q21.3 | c.582T>G |
WAS | 301000 | WAS | Xp11.23-p11.22 | c.3416>A |
CHS | 214500 | LYST | 1q42.1-q42.2 | c.1902dupA |
APDS | 615513 | PIK3CD | 1p36.22 | c.3061G>A |
APDS-2 | 616005 | PIK3R1 | 5q13.1 | c.1425+1G>C,T |
X-SCID | 300400 | IL2RG | Xq13.1 | K97X |
ADA-SCID | 102700 | ADA | 20q13.12 | R156H |
X-CGD | 306400 | CYBB | Xp21.1-p11.4 | P415H |